SOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.TherapyZacks Investment Research · 1 day ago
SOLV Energy to Report Third Quarter 2026 Financial Results on November 12, 2026GlobeNewsWire · 2 days ago
Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*PRNewsWire · 5 days ago
Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026PRNewsWire · Oct 15, 2026
Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive?Zacks Investment Research · Oct 8, 2026
Why Solventum (SOLV) is a Top Value Stock for the Long-TermZacks Investment Research · Oct 8, 2026Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 5, 2026 | $1.90 | $2.55 | Beat |
| May 5, 2026 | $1.35 | $1.48 | Beat |
| Feb 26, 2026 | $1.50 | $1.57 | Beat |
| Nov 6, 2025 | $1.43 | $1.50 | Beat |
| Aug 7, 2025 | $1.45 | $1.69 | Beat |
| May 8, 2025 | $1.21 | $1.34 | Beat |